The next breakthrough in cancer treatment?
In our body, we have an innate immune system and an immune system that is…
As one of the leading causes of death worldwide, cancer receives great focus from the life sciences industry. Indeed, it’s the largest therapeutic focus area for biotech and pharma companies, which are working on a large number of therapeutic approaches, including small molecules, T cell therapies, and antibody therapies.
Global cancer drug sales are estimated to reach €221B by 2024. The top 10 blockbuster drugs are sold by big pharma companies, like Roche, Merck, AbbVie, and Bristol-Myers Squibb. Examples of blockbusters include Keytruda, Rituxan, and Herceptin.
Biotech companies are doing a fair bit of the work as well. Read on to keep up to date with the latest oncology research, discoveries, and market developments.
A Guide to Current Therapies in Immuno-Oncology
From a rich history to a growing number of therapies, the immuno-oncology landscape has changed rapidly over the last decade. In this report, we look into its past, discuss present therapeutic approaches, and provide an outlook into its future.
Go to ReportIn our body, we have an innate immune system and an immune system that is…
The Menarini Group, an Italian pharmaceutical and diagnostics company, says that the U.S. Food and…
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the…
Abbisko Therapeutics Co., Ltd. has announced that its CSF-1R inhibitor Pimicotinib has been granted the…
BiVictriX Therapeutics plc has announced positive in vivo data from a toxicity evaluation study with…
Phacilitate’s Advanced Therapies Week took place last week in Miami Beach, Florida. This week, we…
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
French biotech company Onxeo S.A. has given an update on the clinical development program of…
Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of…
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan…
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…